| |
| |
|
| Insider
Information: |
Aguilar-Cordova Estuardo |
| Relationship: |
Director, 10% Owner |
| City: |
Needham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,097,032 |
|
|
Indirect Shares
|
2,074,942 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,171,974 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Candel Therapeutics, Inc. |
CADL |
Director, 10% Owner |
2022-05-06 |
1,097,032 |
2022-05-06 |
2,074,942 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
3 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADL |
Candel Therapeutics, Inc. |
Director |
– • • |
2022-05-06 |
4 |
OE |
$1.46 |
$197,367 |
D/D |
135,183 |
1,151,106 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Director |
– • • |
2022-05-06 |
4 |
D |
$3.65 |
$197,370 |
D/D |
(54,074) |
1,097,032 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Scientific Officer |
• • – |
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
162,137 |
1,015,923 |
0 |
- |
|
3 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
